Severe Covid-19 symptoms 5 times more likely in patients who got Sinovac rather than Pfizer jab: Study Asia News Network (ANN) is the leading regional alliance of news titles striving to bring the region closer, through an active sharing of editorial content on happenings in the region.
SINGAPORE - Recipients of the Sinovac-CoronaVac vaccine are five times more likely to experience severe Covid-19 symptoms when they are infected than those who had the Pfizer-BioNTech/Comirnaty vaccine. Sinovac recipients are also more than twice as likely to be infected with Covid-19 than Pfizer vaccine recipients and almost six times more likely than those who took the Moderna vaccine. These.
SINGAPORE (The Straits Times/Asia News Network): Recipients of the Sinovac-CoronaVac vaccine are five times more likely to experience severe Covid-19 symptoms when they are infected than those who had the Pfizer-BioNTech/Comirnaty vaccine.